Baxter International Inc. (BAX)
BAX stock forecast: what analysts expect
Wall Street analysts covering Baxter International Inc. currently rate the stock a Hold on average, with a mean 12-month price target of $28.73 — +6.6% versus the last price of $26.95. Targets reflect analyst opinion, not a guarantee.
BAX historical returns
Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in BAX.
BAX annual returns by year
Congress trading in BAX
9 members of Congress have disclosed trading BAX — 11 purchases and 10 sales worth an estimated $192,500. Most recent disclosure: Oct 30, 2025.
See who in Congress traded BAX →About Baxter International Inc.
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
BAX Key Statistics
BAX in plain English
- ROE (-14.37%) — how efficiently the company turns shareholders' money into profit. Negative means it's currently losing money on that equity.
- Profit margin (-9.27%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend yield (0.14%) — the cash payout you'd earn per year as a % of the share price, on top of any price gains.
BAX stock: frequently asked questions
What is Baxter International Inc.'s stock price today?
Baxter International Inc. (BAX) last traded at $26.95 on the NYSE. Over the past 52 weeks the stock has traded between $15.73 and $30.00.
Is BAX stock a buy or a sell?
Wall Street analysts' consensus rating on BAX is "Hold", with an average 12-month price target of $28.73 — about +6.6% versus the current price of $26.95. Analyst targets are opinions, not guarantees; always do your own research.
How much would $1,000 invested in BAX 10 years ago be worth today?
A $1,000 investment in Baxter International Inc. made 10 years ago would be worth about $672 today (dividends reinvested) — a total return of -33%, or -3.9% per year.
Does BAX pay a dividend?
Yes. Baxter International Inc. currently pays a dividend yielding about 0.14% per year at today's share price.
Do members of Congress trade BAX stock?
Yes — 9 members of Congress have disclosed trades in BAX under the STOCK Act, totaling 11 purchases and 10 sales worth an estimated $192,500.
What is Baxter International Inc.'s ticker symbol?
Baxter International Inc. trades under the ticker symbol BAX on the NYSE.
Compare BAX with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.